Abstract: Methodological Considerations for the Implementation of a European Mandated Retrospective Drug Utilisation Study (DUS) to Investigate the Use of Dexmedetomidine (Dexdor®) in Clinical Practice

 

Abstract: Methodological Considerations for the Implementation of a European Mandated Retrospective Drug Utilisation Study (DUS) to Investigate the Use of Dexmedetomidine (Dexdor®) in Clinical Practice

Dexmedetomidine was approved for ICU sedation in adults in the EU in 2011, but has been available in other countries since 1999 and used in many different clinical situations including in children. This study evaluated off-label use of dexmedetomidine in usual care in the EU.